Spotlight: Corporate Member of the Month, September, 2022

Week 2 (September 12): Regeneron

NASP is pleased to shine a bright light this week on Regeneron, the second corporate member to be featured in the month of September.

Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines. Regeneron’s unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in the company’s laboratories.

For contact information and to learn more about Regeneron, please click here.